Multiple multiparity is a negative prognostic factor for endometrial cancer in Poland.
Nulliparity is one of the most important reproductive risk factors for endometrial cancer. It is still discussed whether multiparity implies a more favorable course of the disease and higher overall survival rates. The aim of the study was to analyze the effect of parity on the overall survival of endometrial cancer patients in Poland.



A retrospective analysis of parity on survival rates was performed in 810 women treated surgically for endometrial cancer in a single referential center of gynecological oncology.



Higher parity was shown to be associated with significantly lower survival rates (p=0.03). Parity turned out to be an independent prognostic factor of survival (HR 1.9). Multiple multiparous women were older at the time of surgery, more often presented with deep myometrial infiltration and with involvement of the cervical stroma and had higher clinical stages of the cancer (only according to FIGO 1988 classification). The group of multiple multiparous women was characterized by significantly lower recurrence rates. Multiple multiparous women significantly more often presented with lower educational level, more often were diagnosed with comorbidities and a history of other malignancies, while breast cancer and colon cancer were of lesser evidence in multiple multiparous endometrial cancer patients.



Multiparity turns out to be an unfavorable prognostic factor of survival in Polish women. Unfavorable prognosis in endometrial cancer patients in this group is associated with interactions between risk factors and negative prognostic factors, i.e. the conditions of tumor growth, rather than with the nulliparity itself.
Klinika Ginekologii, Ginekologii Onkologicznej i Endokrynologii Ginekologicznej, Gdański Uniwersytet Medyczny, Gdańsk, Polska. anabacjew@gumed.edu.pl.
Anna O
AO
Abacjew-Chmyłk
Łukasz
Ł
Chmyłko
Dariusz Grzegorz
DG
Wydra
Hanna
H
Olszewska
Paulina
P
Kobiela
Katarzyna
K
Ciach
D000328:Adult; D000367:Age Factors; D018572:Disease-Free Survival; D016889:Endometrial Neoplasms / Q000401:mortality* / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010298:Parity; D011044:Poland; D011379:Prognosis; D012189:Retrospective Studies; D016387:Women's Health